Details for New Drug Application (NDA): 207040
✉ Email this page to a colleague
The generic ingredient in TRAVOPROST is travoprost. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the travoprost profile page.
Summary for 207040
Tradename: | TRAVOPROST |
Applicant: | Lupin Ltd |
Ingredient: | travoprost |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 207040
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.004% | ||||
Approval Date: | May 3, 2024 | TE: | AT | RLD: | No |
Complete Access Available with Subscription